554 results match your criteria: "Centre cardiologique du Nord[Affiliation]"
JACC Cardiovasc Interv
November 2023
Department of Cardiology, Shaare Zedek Medical Centre, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address:
Arch Cardiovasc Dis
December 2023
Cardiology-Heart Rhythm Management Department, Clinique Pasteur, 31076 Toulouse, France; Vrije Universiteit Brussel (VUB), 1050 Brussels, Belgium. Electronic address:
Background: Implantable cardioverter-defibrillators reduce mortality, but the electric shocks delivered can impact the patient's quality of life. Patient education is an efficient way to reduce the stress related to both the device and the disease.
Aims: We assessed the evolution of knowledge and satisfaction of implantable cardioverter-defibrillator recipients regarding their cardiac disease, implantable cardioverter-defibrillator implantation, follow-up complications, remote monitoring and daily life recommendations.
Catheter Cardiovasc Interv
December 2023
Cardiology Department, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.
Background: The Synergy Megatron is an everolimus-drug eluting stent that may offer advantages in the treatment of aorto-ostial disease and large proximal vessels.
Aims: To report the short- to medium-term clinical outcomes from the European Synergy Megatron Implanters' Registry.
Methods: This registry was an investigator-initiated study conducted at 14 European centers.
Viruses
September 2023
Department of Cardiac Surgery, Centre Cardiologique du Nord, 93200 Saint-Denis, France.
Aortic dissection is a clinicopathological entity caused by rupture of the intima, leading to a high mortality if not treated. Over time, diagnostic and investigative methods, antihypertensive therapy, and early referrals have resulted in improved outcomes according to registry data. Some data have also emerged from recent studies suggesting a link between Human Cytomegalovirus (HCMV) infection and aortic dissection.
View Article and Find Full Text PDFLife (Basel)
September 2023
Department of Cardiovascular Surgery, Instituto de Neurologia e Cardiologia de Curitiba-INC Cardio, Curitiba 81210-310, Parana, Brazil.
Infective valve endocarditis is caused by different pathogens and 60% of those involve the aortic valve with valve failure. Although is recognized as the most frequently isolated causative bacterium associated with IE in high-income countries, Gram-positive cocci nevertheless play a crucial role in promoting infection in relation to their adhesive matrix molecules. The presence of pili on the surface of Gram-positive bacteria such as in different strains of and spp.
View Article and Find Full Text PDFMicroorganisms
October 2023
Department of Cardiac Surgery, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, 94000 Creteil, France.
() is a commensal bacterium that causes various infections in surgical sites, the urinary tract, and blood. The bacterium is becoming a significant concern because it tends to affect the elderly population, which has a high prevalence of undiagnosed degenerative valvular disease and is often subjected to invasive procedures and implanted medical devices. The bacterium's actions are influenced by specific characteristics like pili activity and biofilm formation.
View Article and Find Full Text PDFJ Am Coll Cardiol
November 2023
Department of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address:
Eur Heart J Case Rep
October 2023
Cardiology Department, Centre Cardiologique du Nord, 32-36 Rue des Moulins Gémeaux, Saint-Denis 93200, France.
Background: The use of trans-catheter treatment for tricuspid regurgitation (TR) is currently increasing, especially trans-catheter edge-to-edge repair (TEER). However, patients with very large coaptation gaps are usually considered not eligible for this treatment.
Case Summary: We present the case of an 87-year-old man with symptomatic [New York Heart Association (NYHA) functional Class IV, right-sided heart failure signs] isolated torrential TR due to chronic atrial fibrillation who was initially considered not eligible for a tricuspid valve (TV) TEER because of a very large coaptation gap.
J Clin Med
September 2023
Department of Cardiothoracic Surgery, Hôpital Pitié-Salpêtrière, Boulevard de Hôpital 47-83, 75013 Paris, France.
Heliyon
October 2023
Cardiac Surgery, Molinette Hospital, University of Turin, Turin, Italy.
Background: Acute type A aortic dissection (TAAD) is associated with significant mortality and morbidity. In this study we evaluated the prognostic significance of preoperative arterial lactate concentration on the outcome after surgery for TAAD.
Methods: The ERTAAD registry included consecutive patients who underwent surgery for acute type A aortic dissection (TAAD) at 18 European centers of cardiac surgery.
Heart
January 2024
Clinical Investigation Center 1430, APHP, Groupe Hospitalier Henri Mondor, Creteil, France
Objective: Left atrial appendage closure (LAAC) is recommended to decrease the stroke risk in patients with atrial fibrillation and contraindications to anticoagulation. However, age-stratified data are scarce. The aim of this study was to provide information on the safety and efficacy of LAAC, with emphasis on the oldest patients.
View Article and Find Full Text PDFInt J Mol Sci
September 2023
Department of Cardiac Surgery, Centre Cardiologique du Nord, 93200 Saint-Denis, France.
The discovery of miRNAs and their role in disease represent a significant breakthrough that has stimulated and propelled research on miRNAs as targets for diagnosis and therapy. Cardiovascular disease is an area where the restrictions of early diagnosis and conventional pharmacotherapy are evident and deserve attention. Therefore, miRNA-based drugs have significant potential for development.
View Article and Find Full Text PDFJACC Cardiovasc Imaging
January 2024
Valve Science Center, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA. Electronic address:
Tricuspid regurgitation (TR) is a highly prevalent and heterogeneous valvular disease, independently associated with excess mortality and high morbidity in all clinical contexts. TR is profoundly undertreated by surgery and is often discovered late in patients presenting with right-sided heart failure. To address the issue of undertreatment and poor clinical outcomes without intervention, numerous structural tricuspid interventional devices have been and are in development, a challenging process due to the unique anatomic and physiological characteristics of the tricuspid valve, and warranting well-designed clinical trials.
View Article and Find Full Text PDFJ Cardiovasc Comput Tomogr
November 2023
Department of Cardiology, University of Galway, Galway, Ireland.
Ann Transl Med
August 2023
Department of Cardiothoracic Surgery, Royal Infirmary of Edinburgh, Edinburgh, UK.
Eur Heart J
February 2024
Department of Cardiology, University of Ottawa Heart Institute, Ottawa, Canada.
Background And Aims: Benefit of tricuspid regurgitation (TR) correction and timing of intervention are unclear. This study aimed to compare survival rates after surgical or transcatheter intervention to conservative management according to a TR clinical stage as assessed using the TRI-SCORE.
Methods: A total of 2,413 patients with severe isolated functional TR were enrolled in TRIGISTRY (1217 conservatively managed, 551 isolated tricuspid valve surgery, and 645 transcatheter valve repair).
J Am Coll Cardiol
October 2023
Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:
Background: The optimal antithrombotic therapy following left atrial appendage occlusion (LAAO) in patients with nonvalvular atrial fibrillation (AF) remains uncertain.
Objectives: In this study, the authors sought to compare the efficacy and safety of various antithrombotic strategies after LAAO.
Methods: We searched the Medline, Cochrane, EMBASE, LILACS, and ClinicalTrials.
Front Cardiovasc Med
July 2023
Department of Neurology and Stroke Unit, Bichat Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
The detection of atrial fibrillation (AF) in patients with cryptogenic stroke (CS) is an essential part of management to limit the risk of recurrence. However, in practice, not all patients who need AF screening are screened, or are screened with significant delays. The disparities of access to examinations, their costs as well as the increasing workload require an evolution of practices both in terms of organization and the type of equipment used.
View Article and Find Full Text PDFFront Cardiovasc Med
July 2023
Department of Cardiac Electrophysiology and Arrhythmology, Clinica Montevergine, Mercogliano, Italy.
Background: Highly localized impedance (LI) measurements during atrial fibrillation (AF) ablation have the potential to act as a reliable predictor of the durability of the lesions created.
Objective: We aimed to collect data on the procedural parameters affecting LI-guided ablation in a large multicenter registry.
Methods: A total of 212 consecutive patients enrolled in the CHARISMA registry and undergoing their first pulmonary vein (PV) isolation for paroxysmal and persistent AF were included.
Int J Mol Sci
July 2023
Department of Cardiothoracic Surgery, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK.
sp. are the most commonly associated pathogens in infective endocarditis, especially within high-income nations. This along with the increasing burden of healthcare, aging populations, and the protracted infection courses, contribute to a significant challenge for healthcare systems.
View Article and Find Full Text PDFWorld J Surg
November 2023
Heart and Lung Center, Helsinki University Hospital, University of Helsinki, 00029, Helsinki, Finland.
J Thorac Dis
June 2023
Department of Cardiopulmonary Circulation, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Background: Data are quite sparse on the comprehensive analyses of pulmonary hypertension (PH) clinical trials worldwide.
Methods: Information including participating countries (developed or developing), intervention type, trial size, PH categories, sponsorship, study phase, design strategies, and participants' demographic characteristics was extracted from PH trials registered on ClinicalTrials.gov from 1999 to 2021.
J Cardiovasc Dev Dis
June 2023
Department of Cardiac Surgery, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, 94000 Creteil, France.
Type A acute aortic dissection is associated with significant morbidity and mortality, with prompt referral imaging and management to tertiary referral centers needed urgently. Surgery is usually needed emergently, but the choice of surgery often varies depending on the patient and the presentation. Staff and center expertise also play a major role in determining the surgical strategy employed.
View Article and Find Full Text PDFJ Cardiovasc Dev Dis
June 2023
Department of Cardiothoracic Surgery, Hôpital Pitié-Salpêtrière, Boulevard de Hôpital 47-83, 75013 Paris, France.
The indications for cryopreserved allografts in aortic valve replacement are still debatable. We aim to identify factors influencing early and long-term durability of the aortic homograft and to define subgroups of patients with an improved long-term quality of life, survival, and freedom from structural valve degeneration (SVD). We evaluated our series of 210 patients who underwent allograft implantation with a retrospective cohort study design over a period of 20 years.
View Article and Find Full Text PDFCancers (Basel)
April 2023
Department of Medical Thoracic and Medical Oncology, AP-HP, Avicenne University Hospital, 93000 Bobigny, France.
: We aimed to evaluate the prognostic value of imaging biomarkers on 18F-FDG PET/CT in extensive-stage small-cell lung cancer (ES-SCLC) patients undergoing first-line chemo-immunotherapy. In this multicenter and retrospective study, we considered two cohorts, depending on the type of first-line therapy: chemo-immunotherapy (CIT) versus chemotherapy alone (CT). All patients underwent baseline 18-FDG PET/CT before therapy between June 2016 and September 2021.
View Article and Find Full Text PDF